Literature DB >> 6818604

Haloperidol-induced plasma prolactin release: sensitivity, reliability, and comparison to haloperidol antagonism of dopamine agonist-induced stereotyped behavior in the rat.

J J Feigenbaum, B H Moon, R Catterton, J Yanai, H L Klawans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6818604     DOI： 10.1007/bf00433748

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  6 in total

1.  Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.

Authors:  A C Sayers; H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

2.  The use of the prolactin response in clinical psychopharmacology [proceedings].

Authors:  E J Sachar; P H Gruen; N Altman
Journal:  Psychopharmacol Bull       Date:  1977-01

3.  Dopamine and the pharmacology of schizophrenia: the state of the evidence.

Authors:  S Matthysse
Journal:  J Psychiatr Res       Date:  1974       Impact factor: 4.791

4.  Antipsychotic drugs stimulate prolactin release.

Authors:  J A Clemens; E B Smalstig; B D Sawyer
Journal:  Psychopharmacologia       Date:  1974

5.  Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats.

Authors:  G P Mueller; J Simpkins; J Meites; K E Moore
Journal:  Neuroendocrinology       Date:  1976       Impact factor: 4.914

6.  Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs.

Authors:  A S Horn; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.